Pharmaceutical companies face increasing challenges with outdated paper-based systems that hinder compliance and limit patient access to vital information. The pressure is growing as digital transformation becomes essential, making ePI implementation / e-labelling implementation a priority for the industry. By aligning with the latest EMA labelling guidelines, organizations can ensure compliance while improving efficiency, transparency, and patient trust.

What are the first steps in a successful epi implementation?

The first step in a successful ePI implementation is to analyze your current product information processes and determine where digitization can add the most impact. Many organizations still depend on static paper leaflets, which limit flexibility in updating safety details, translating content, and ensuring timely regulatory compliance. Transitioning to digital formats allows for structured, efficient, and interoperable data exchange.

The European Medicines Agency (EMA) has introduced the EU ePI Common Standard, based on Fast Healthcare Interoperability Resources (FHIR), to create structured, machine-readable information that can be used across healthcare systems. Preparing for this standard requires assessing existing IT systems, evaluating readiness for integration, and aligning workflows with regulatory expectations.

A recommended first step is initiating a pilot project, typically starting with centrally authorized products before scaling to wider portfolios. Organizations also benefit from training staff, re-designing internal workflows, and developing robust change management strategies.

Business process experts for managing electronic product information provide practical guidance on implementing ePI, outlining how structured, digital formats can improve both compliance and patient access. By following a phased roadmap and leveraging expert insights, companies can ensure a smooth and compliant transition to ePI while staying aligned with evolving EMA requirements.

How do EMA labelling guidelines shape your e-labelling implementation strategy?

The EMA labelling guidelines strongly influence every aspect of an e-labelling implementation strategy. They define the mandatory structure of documents such as the Summary of Product Characteristics (SmPC), Patient Information Leaflet (PIL), and labelling elements, ensuring consistency across the European Union. These guidelines are essential in maintaining clarity, transparency, and multilingual compliance.

From a strategic perspective, aligning with EMA requirements means organizations must adopt standardized QRD templates, prepare for FHIR-based data structures, and ensure their processes support frequent updates. Since e-labelling enables real-time access to updated information, companies must establish internal systems that allow quick revisions while maintaining accuracy and regulatory approval.

Digital formats also facilitate improved accessibility for patients and healthcare providers, making product information more interactive and user-friendly. They are particularly valuable for enhancing transparency in multilingual markets, where timely updates are crucial.

Support in navigating these changes can be found through partners such as Billev Pharma East, who provide expertise in regulatory strategy and digital transformation of pharmaceutical documentation. By aligning early with EMA labelling guidelines, companies not only ensure compliance but also strengthen efficiency and trust in their communication with both regulators and end-users.

What common challenges arise during epi implementation and how can you overcome them?

One of the main challenges in ePI implementation is adapting existing organizational processes to a digital-first approach. Many companies face internal resistance when moving away from familiar paper-based systems. Training and clear change management strategies are therefore essential to foster acceptance among regulatory, IT, and quality teams.

Another obstacle lies in the technical complexity of adopting the EU ePI Common Standard. This requires IT infrastructure that can handle structured, FHIR-based formats, along with integration into regulatory submission tools like EMA’s Product Lifecycle Management (PLM) portal. Smaller organizations, in particular, may struggle with the resources and expertise required for these technical upgrades.

Language diversity across the EU also presents challenges. Since product information must be compliant in all required languages, maintaining consistency and accuracy across multiple versions can strain resources. Companies need structured workflows, translation management tools, and robust quality assurance practices to manage this efficiently.

Overcoming these challenges involves a phased approach: starting with pilot projects, building internal capacity gradually, and engaging with external experts when needed. Collaboration with regulatory authorities and proactive alignment with EMA guidance are equally important. By planning early and breaking the process into manageable steps, organizations can ensure a smoother transition and avoid costly compliance risks.

Integration with existing IT systems: a critical bottleneck

One of the most pressing challenges in ePI implementation lies in integrating electronic product information processes into existing IT infrastructures. While the transition to digital formats promises efficiency and compliance, many organizations discover that their current systems are not fully equipped to manage structured, FHIR-based data or to connect seamlessly with regulatory submission platforms.

This lack of integration often leads to delays, additional manual work, and frustration across regulatory and IT teams. Companies may find themselves struggling with insufficient tools, limited automation, and complex workflows that slow down the adoption of ePI.

A practical way to overcome these difficulties is to begin with a comprehensive IT gap analysis that identifies missing functionalities and prioritizes the upgrades needed for compliance. Collaboration with technology providers and proactive engagement with regulators can also ease the transition, ensuring that systems are compatible with the latest requirements.

Another effective strategy is to phase the implementation gradually. Starting with a limited product portfolio allows organizations to test their systems, refine processes, and make necessary improvements before scaling to all medicines. By approaching integration as a step-by-step process rather than a single disruptive change, companies can reduce risks and achieve smoother, more sustainable results.

How can e-labelling implementation improve regulatory compliance and efficiency?

A carefully planned e-labelling implementation can significantly enhance regulatory compliance and streamline operations. By shifting from paper leaflets to structured digital formats, companies can update product information in real time, ensuring that patients and healthcare professionals always access the most accurate details. This reduces compliance risks and supports alignment with EMA labelling guidelines, which emphasize clarity, transparency, and timely updates.

Structured digital content also allows automated checks against QRD templates, helping to prevent errors and avoid costly delays in regulatory submissions. In addition, electronic formats improve traceability and version control, which are critical during audits and inspections.

From an efficiency perspective, e-labelling implementation reduces manual workloads, simplifies translation management, and accelerates approval cycles. Updates can be distributed instantly across multiple channels instead of reprinting and shipping paper leaflets. This creates a faster, more reliable process that benefits regulators, companies, and patients alike.

By combining compliance with efficiency, e-labelling implementation is no longer just a regulatory requirement but a strategic opportunity to modernize workflows and deliver better healthcare outcomes.

What role does digital transformation play in aligning with ema labelling guidelines?

Digital transformation is central to aligning with EMA labelling guidelines. Through ePI implementation, organizations can transition from static documents to dynamic, interoperable formats that meet the latest regulatory standards. This digital shift supports compliance while creating opportunities for innovation in how information is shared with healthcare professionals and patients.

The EMA’s move toward electronic product information reflects its vision for greater accessibility and harmonization across the EU. By adopting structured, FHIR-based formats, companies ensure their product data can be integrated into national eHealth platforms, making updates faster and more reliable.

Digital transformation also improves usability. Patients no longer need to rely solely on paper leaflets; instead, they can access digital labels through mobile apps, QR codes, or online portals. This enhances transparency and supports EMA’s broader goals of patient engagement and safety.

For companies, embracing digital transformation means investing in systems that support e-labelling implementation while remaining flexible enough to adapt to future changes in EMA labelling guidelines. The result is a sustainable framework that benefits all stakeholders.

Key aspects of digital transformation in EPI implementation

Digital transformation directly supports compliance with EMA labelling guidelines by enabling structured, interoperable, and patient-friendly product information. Through ePI implementation / e-labelling implementation, companies can move away from static documents and embrace dynamic formats that are easier to update, distribute, and integrate with healthcare systems.

To highlight the impact, the table below summarizes the main benefits of digital transformation for regulatory alignment and operational efficiency:

By leveraging digital transformation, companies not only meet regulatory obligations but also build more efficient internal systems and improve transparency for patients and healthcare professionals.

How should you prepare your organization for a smooth epi implementation process?

Preparation is key for a successful ePI implementation. The process begins with a gap analysis to identify where current systems fall short of EMA labelling guidelines. Organizations must evaluate IT infrastructure, data quality, and internal workflows to ensure readiness for structured, digital formats.

Building a cross-functional project team is essential. Since ePI implementation impacts regulatory affairs, quality assurance, IT, and commercial departments, all stakeholders should be aligned from the start. Training programs should address both technical skills and regulatory knowledge, ensuring teams understand the importance of compliance and efficiency.

On the technical side, companies need to invest in content management systems that support e-labelling implementation and interoperability with EMA’s Product Lifecycle Management (PLM) portal. Early piloting with a limited product portfolio helps test the systems, refine processes, and build confidence before full-scale rollout.

By preparing thoroughly, companies can reduce risks, speed up approvals, and ensure that their ePI implementation aligns seamlessly with EMA labelling guidelines, creating a strong foundation for digital transformation.

What future trends in e-labelling implementation are expected under evolving ema labelling guidelines?

Future trends in e-labelling implementation will be shaped by ongoing digitalization efforts and the evolution of EMA labelling guidelines. One major trend is interoperability: structured, FHIR-based product information will become standard, ensuring seamless integration into healthcare systems and electronic medical records.

Another trend is increased interactivity. Future e-labels are expected to go beyond static text, offering multimedia instructions, patient-friendly summaries, and hyperlinks to trusted resources. This will improve patient understanding and engagement while maintaining compliance with EMA labelling guidelines.

Automation and artificial intelligence will also play a growing role in ePI implementation and e-labelling implementation. These technologies can streamline translation, improve quality checks, and accelerate regulatory submissions, reducing the burden on internal teams.

Finally, real-time updates will become the norm, requiring companies to maintain agile IT systems capable of frequent, compliant revisions. Organizations that prepare early for these trends will be better positioned to adapt to evolving regulatory expectations and to lead innovation in patient communication.

Read also:

• How does e-labelling help us understand what is electronic product information?
• What is structured product labeling and why is it essential for high-quality EPI?
• Choosing the right EPI solution? Start with the PLM Portal

Sources: 1 – European Medicines Agency. (2023). Electronic product information (ePI), 2 – European Medicines Agency. (2022). Successful pilot paves way for implementation of electronic product information (ePI), 3 – European Medicines Agency. (2023). PLM Portal guidance (Knowledge article KA-01081), 4 – European Medicines Agency. (2023). EU ePI Common Standard (FHIR IG), 5 – European Medicines Agency. (2022). Successful pilot paves way for implementation of electronic product information (ePI), 6 – European Medicines Agency. (2022). Electronic product information (ePI): Report on the experience gained during regulatory procedures for EU medicines (EMA/763513/2021), 7 – European Medicines Agency. (2021). Next steps for ePI and roadmap development [Presentation by J. Garcia].